A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes

Aims. Basal insulin plus oral hypoglycemic agents (OHAs) has not been investigated for early intensive antihyperglycemic treatment in people with newly diagnosed type 2 diabetes. This study is aimed at comparing the short-term (over a period of 12 days) effects of basal insulin glargine plus OHAs an...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shuo Lin, Mu Chen, Wanling Chen, Keyi Lin, Panwei Mu, Bilian Zhu, Wen Xu, Manman Wang, Jianping Weng, Longyi Zeng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2018-01-01
Colecção:	Journal of Diabetes Research
Acesso em linha:	http://dx.doi.org/10.1155/2018/2791584
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!